Light therapy for early Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This study tests a type of light therapy (called transcranial photobiomodulation) to see if it can help people with early-stage Alzheimer's. It involves coming to Cedars-Sinai for weekly sessions over a period of time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 89 years old.
- You have mild cognitive impairment or mild dementia due to Alzheimer's disease.
- You do not have other major brain conditions like epilepsy or a history of seizures.
- You are able to come to Cedars-Sinai for weekly in-person visits.
- If you take Alzheimer's medication, you've been on a stable dose for at least a month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a non-invasive 40 Hz light therapy system can help people with early Alzheimer’s. You’ll likely use the device at home and wear a small activity monitor, while doing memory and thinking tests.
This study tests whether regular at-home “gamma” light and sound stimulation can help people with mild Alzheimer’s. Participants start with a month at home and are followed to see how they do during treatment.
This study tests a light therapy that shines near-infrared light on the head to see if it can improve memory and thinking in people with mild to moderate Alzheimer's disease. It is an early-stage trial, so the main goal is to check safety and see if the treatment shows promise.
This trial tests if shining a special light through the scalp and nose can help people with mild memory or thinking problems. It aims to slow down memory decline and improve daily life.
This study tests whether light therapy can help improve thinking and memory in older adults with mild cognitive changes. Researchers will use light exposure to see if it supports brain health in people with signs of blood vessel disease in the brain.
This study tests if a near-infrared light therapy device can help improve memory and thinking in people with mild to moderate Alzheimer's disease. It involves daily treatment sessions with the device, and a study partner must be available to help with treatment.
Hear when a new Alzheimer’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.